<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03445130</url>
  </required_header>
  <id_info>
    <org_study_id>16-01844</org_study_id>
    <nct_id>NCT03445130</nct_id>
  </id_info>
  <brief_title>A Study of the Effects of Lavender Aromatherapy on Preoperative Anxiety in Breast Surgery Patients</brief_title>
  <official_title>A Randomized Prospective Placebo-Controlled Study of the Effects of Lavender Aromatherapy on Preoperative Anxiety in Breast Surgery Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effects of lavender aromatherapy on
      preoperative anxiety by measuring changes in pulse rate and anxiety core using Spielberger
      State-Trait Anxiety Index questionnaires and on postoperative pain medicine usage. Study
      participants will then be randomized into one of four groups; either they will receive 2
      drops of lavender (Lavandula Angustifolia) oil (LO) or 2 drops of Michelia Alba Leaf oil (MA)
      or 2 drops of unscented Almond oil (AO) or two drops water on the inside of an oxygen face
      mask for 15 minutes. Linalool makes up ~30% of Lavandula Angustifolia oil and is believed to
      be its most active anti-anxiety component. Before and after treatment, anxiety level will be
      measured using the Spielberger State-Trait Anxiety Inventory.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 10, 2019</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in anxiety as measured by the change in baseline STAI scores</measure>
    <time_frame>20 Minutes</time_frame>
    <description>Spielberger State-Trait Anxiety Inventory (STAI) is a self-reported instrument. It was designed to assess levels of state anxiety and traint anxiety, through 40 items scored by a likert-scale. State anxiety can be defined as a transient momentary emotional status that results from situational stress.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Anxiety</condition>
  <arm_group>
    <arm_group_label>Lavandula Angustifolia oil (LO)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2 Drops in Oxygen Mask</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Michelia Alba Leaf oil (MA)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2 Drops in Oxygen Mask</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Almond oil (AO)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2 Drops in Oxygen Mask</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Water</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2 Drops in Oxygen Mask</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Lavandula Angustifolia oil (LO)</intervention_name>
    <description>two drops on the inside of an oxygen face mask for 15 minutes.</description>
    <arm_group_label>Lavandula Angustifolia oil (LO)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Michelia Alba Leaf oil (MA)</intervention_name>
    <description>two drops on the inside of an oxygen face mask for 15 minutes.</description>
    <arm_group_label>Michelia Alba Leaf oil (MA)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Almond oil (AO)</intervention_name>
    <description>two drops on the inside of an oxygen face mask for 15 minutes.</description>
    <arm_group_label>Almond oil (AO)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Water</intervention_name>
    <description>two drops on the inside of an oxygen face mask for 15 minutes.</description>
    <arm_group_label>Water</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women, older than 18, American Society of Anesthesiologists (ASA) classification
             I-III, undergoing elective breast surgery on Tisch 10th floor Day Surgery. Cancer
             patients are included.

        Exclusion Criteria:

          -  History of asthma, bronchitis, COPD, contact dermatitis to cosmetic fragrances,
             positive patch test, pregnancy, and significant laboratory abnormalities.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Women undergoing breast surgery</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Wajda, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York Langone Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lola Franco, MD</last_name>
    <phone>212 263 0531</phone>
    <email>lola.franco@nyulangone.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>NYU Langone Health</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lola Franco</last_name>
      <phone>212-263-0531</phone>
      <email>Lola.Franco@nyulangone.org</email>
    </contact>
    <investigator>
      <last_name>Michael Wajda, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>February 20, 2018</study_first_submitted>
  <study_first_submitted_qc>February 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 26, 2018</study_first_posted>
  <last_update_submitted>May 18, 2020</last_update_submitted>
  <last_update_submitted_qc>May 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Preoperative Anxiety</keyword>
  <keyword>Breast Surgery</keyword>
  <keyword>Lavender Aromatherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All of the individual participant data collected during the trial, after deidentification. Researchers who provide a methodologically sound proposal.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>Beginning 9 months and ending 36 months following article publication.</ipd_time_frame>
    <ipd_access_criteria>Requests should be directed to Lola.Franco@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

